ACE inhibitors may increase risk of recurrence in breast cancer survivors

ACE inhibitors, commonly used to control high blood pressure and heart failure in women, may be associated with an increased risk of recurrence in women who have had breast cancer, according to a study by researchers at UCLA's Jonsson Comprehensive Cancer Center.

Read the whole article on Physorg

More from Physorg